These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12063441)

  • 1. [Low-dose combination oral contraceptives use in women with uterine leiomyomas].
    Orsini G; Laricchia L; Fanelli M
    Minerva Ginecol; 2002 Jun; 54(3):253-61. PubMed ID: 12063441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.
    Halbe HW; de Melo NR; Bahamondes L; Petracco A; Lemgruber M; de Andrade RP; da Cunha DC; Guazelli CA; Baracat EC
    Eur J Contracept Reprod Health Care; 1998 Sep; 3(3):113-20. PubMed ID: 9853201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does low-dose combination oral contraceptive use affect uterine size or menstrual flow in premenopausal women with leiomyomas?
    Friedman AJ; Thomas PP
    Obstet Gynecol; 1995 Apr; 85(4):631-5. PubMed ID: 7898846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexible starting schedule for oral contraception: effect on the incidence of breakthrough bleeding and compliance.
    Yeshaya A; Orvieto R; Kaplan B; Dicker D; Bar-Hava I; Bar J; Ben-Rafael Z
    Eur J Contracept Reprod Health Care; 1998 Sep; 3(3):121-3. PubMed ID: 9853202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The desogestrel-ethinyl estradiol combination and overweight: current data].
    Rubio Lotvin B
    Ginecol Obstet Mex; 1995 Nov; 63():483-6. PubMed ID: 8537039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A combiphasic oral contraceptive containing ethinylestradiol and desogestrel].
    Poulsen HK
    Ugeskr Laeger; 1995 Aug; 157(32):4473-5. PubMed ID: 7483033
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body weight change during use of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake.
    Endrikat J; Gerlinger C; Cronin M; Wessel J; Ruebig A; Rosenbaum P; Düsterberg B
    Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):199-204. PubMed ID: 11848649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in the size of a uterine leiomyoma following discontinuation of an estrogen-progestin contraceptive.
    Barbieri RL
    Gynecol Obstet Invest; 1997; 43(4):276-7. PubMed ID: 9194628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J; Daly L; Carroll E
    Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low-dose oral contraceptives on female whole saliva.
    Laine M; Pienihäkkinen K; Ojanotko-Harri A; Tenovuo J
    Arch Oral Biol; 1991; 36(7):549-52. PubMed ID: 1837983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory brainstem response in premenopausal women taking oral contraceptives.
    Caruso S; Maiolino L; Rugolo S; Intelisano G; Farina M; Cocuzza S; Serra A
    Hum Reprod; 2003 Jan; 18(1):85-9. PubMed ID: 12525445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene- and monophasic desogestrel-containing oral contraceptives. Gestodene Study Group.
    Bruni V; Croxatto H; De La Cruz J; Dhont M; Durlot F; Fernandes MT; Andrade RP; Weisberg E; Rhoa M
    Gynecol Endocrinol; 2000 Apr; 14(2):90-8. PubMed ID: 10836195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of contraceptive with 20 ug ethinylestradiol and 150 ug desogestrel on some acute phase proteins].
    Uchikova E; Batashki I; Milchev N; Mateva N; Markova D; Gŭrova A
    Akush Ginekol (Sofiia); 2006; 45(2):39-43. PubMed ID: 16637303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of desogestrel, the first new-generation progestagen, practil 21, on 13,290 women and 74,967 cycles].
    Bilotta P; Favilli S
    Minerva Ginecol; 1987 Dec; 39(12):855-69. PubMed ID: 3329705
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
    Lepot MR; Gaspard UJ
    Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of a low-dose contraceptive--Femodene].
    Rachev E; Damianov L; Dukovski A; Katsarova M
    Akush Ginekol (Sofiia); 1995; 34(3):71-3. PubMed ID: 8787249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments.
    Koyuncu FM; Kuscu NK; Var A; Onur E
    Acta Obstet Gynecol Scand; 2003 Aug; 82(8):767-8. PubMed ID: 12848650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.